J Kevin Buchi Amneal Pharmaceuticals, Inc. (AMRX) insider trading activity
J Kevin Buchi is Director of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 262,072 shares of AMRX, which is worth approximately $2.06 Million. The most recent transaction as insider was on May 10, 2024, when has been sold 76,453 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
262K
0%
3M change
41.19%
12M change
Total Value Held
$2.06 Million
J KEVIN BUCHI Transaction History
Also insider at
JKB
J Kevin Buchi
Director
Boston, MA